Go to content | Main menu | Go to search

Scroll Up Scroll Down

You are about to leave zent2u.com

The link you are about to open is not maintained by Zentiva and may potentially be unsafe.

  • Back To Zent2U
  • Proceed to external link
Close

  • Production sites
  • Available products
  • Technologies
  • News
Menu

News from Zent2U

  • 26 October 2021   /    News

    ZenT2u_article_21-1-21

    Zent2U will be the first offering EU dossier for Finasteride / Tadalafil 5 mg / 5 mg fixed-dose combination

    Show more
  • 12 October 2021   /    News

    ZenT2u_article_21-1-21

    Zent2U announces successful Pivotal BE trial on Sitagliptin development

    Show more
  • 12 August 2021   /    News

    ZenT2u_article_21-1-21

    Zent2U announces completion of bioequivalence trials on Sertraline

    Show more

Load more...

  • Legal Notice
  • GDPR
  • Cookies
  • Sitemap
ZentU Logo

U Kabelovny 529/16 – 102 00

Prague 10, Czech Republic

Tel: +420 267 243 231

Zentiva